跳至主要内容
临床试验/ISRCTN35625202
ISRCTN35625202已完成1 期

Adverse events, acceptability and efficacy of a combined regimen of ulipristal acetate and misoprostol for abortion through 63 days of gestation

Gynuity Health Projects0 个研究点目标入组 166 人开始时间: 2022年8月16日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
166

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Pregnant with estimated gestational age =63 days by ultrasound and desiring an abortion
  • 2. Body mass index (BMI) =32 kg/m²
  • 3. Aged =18 years old or emancipated minor
  • 4. With access to a telephone for follow-up communication
  • 5. Resident of Mexico City
  • 6. Able to provide informed consent

排除标准

  • 1. History of hepatic or renal disease
  • 2. Confirmation or suspicion of ectopic pregnancy, gestational trophoblastic disease or undiagnosed adnexal mass
  • 3. IUD in place
  • 4. History of allergy to ulipristal or misoprostol (or other prostaglandins)
  • 5. Unwilling to or with significant difficulty preventing return to clinic for follow up
  • 6. Unable to provide informed consent

研究者

发起方
Gynuity Health Projects

相似试验